Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

Hair restoration techniques and new cell sources improve hair loss treatments.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

PCOS can cause excess hair growth, oily skin, hair loss, acne, and dark skin patches.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Long-term use of minoxidil may cause hair follicles to transform into noticeable terminal hairs, leading to trichostasis spinulosa.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Female pattern alopecia causes hair thinning due to shrinking hair follicles.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

LLLT is a safe, promising hair loss treatment, but more research needed.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Removing follicular plugging is crucial for effective alopecia treatment.

Androgenetic alopecia is common hair loss caused by genetics and hormones.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Ovariectomy in mice affects hair growth and skin thickness, suggesting potential for obesity treatment research.

STIM1 is essential for sweat secretion.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Certain products and treatments can improve hair health and growth.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

Female pattern hair loss often starts in teenage years, reduces hair density, and can impact quality of life.

Oral Minoxidil may be better for hair growth than topical, but its long-term safety is unclear.